Table of Contents 1 Radiopharmaceuticals in Nuclear Medicine Market Overview 1.1 Radiopharmaceuticals in Nuclear Medicine Product Overview 1.2 Radiopharmaceuticals in Nuclear Medicine Market Segment by Type 1.2.1 Diagnostic Radiopharmaceuticals 1.2.2 Therapy Radiopharmaceuticals 1.2.3 Enriched Stable Isotopes 1.3 Global Radiopharmaceuticals in Nuclear Medicine Market Size by Type 1.3.1 Global Radiopharmaceuticals in Nuclear Medicine Sales and Growth by Type 1.3.2 Global Radiopharmaceuticals in Nuclear Medicine Sales and Market Share by Type (2014-2019) 1.3.3 Global Radiopharmaceuticals in Nuclear Medicine Revenue and Market Share by Type (2014-2019) 1.3.4 Global Radiopharmaceuticals in Nuclear Medicine Price by Type (2014-2019) 2 Global Radiopharmaceuticals in Nuclear Medicine Market Competition by Company 2.1 Global Radiopharmaceuticals in Nuclear Medicine Sales and Market Share by Company (2014-2019) 2.2 Global Radiopharmaceuticals in Nuclear Medicine Revenue and Share by Company (2014-2019) 2.3 Global Radiopharmaceuticals in Nuclear Medicine Price by Company (2014-2019) 2.4 Global Top Players Radiopharmaceuticals in Nuclear Medicine Manufacturing Base Distribution, Sales Area, Product Types 2.5 Radiopharmaceuticals in Nuclear Medicine Market Competitive Situation and Trends 2.5.1 Radiopharmaceuticals in Nuclear Medicine Market Concentration Rate 2.5.2 Global Radiopharmaceuticals in Nuclear Medicine Market Share of Top 5 and Top 10 Players 2.5.3 Mergers & Acquisitions, Expansion 3 Radiopharmaceuticals in Nuclear Medicine Company Profiles and Sales Data 3.1 Bracco Imaging S.P.A. 3.1.1 Company Basic Information, Manufacturing Base and Competitors 3.1.2 Radiopharmaceuticals in Nuclear Medicine Product Category, Application and Specification 3.1.3 Bracco Imaging S.P.A. Radiopharmaceuticals in Nuclear Medicine Sales, Revenue, Price and Gross Margin(2014-2019) 3.1.4 Main Business Overview 3.2 Cambridge Isotope Laboratories, Inc. 3.2.1 Company Basic Information, Manufacturing Base and Competitors 3.2.2 Radiopharmaceuticals in Nuclear Medicine Product Category, Application and Specification 3.2.3 Cambridge Isotope Laboratories, Inc. Radiopharmaceuticals in Nuclear Medicine Sales, Revenue, Price and Gross Margin(2014-2019) 3.2.4 Main Business Overview 3.3 Cardinal Health, Inc. 3.3.1 Company Basic Information, Manufacturing Base and Competitors 3.3.2 Radiopharmaceuticals in Nuclear Medicine Product Category, Application and Specification 3.3.3 Cardinal Health, Inc. Radiopharmaceuticals in Nuclear Medicine Sales, Revenue, Price and Gross Margin(2014-2019) 3.3.4 Main Business Overview 3.4 Covidien, Plc 3.4.1 Company Basic Information, Manufacturing Base and Competitors 3.4.2 Radiopharmaceuticals in Nuclear Medicine Product Category, Application and Specification 3.4.3 Covidien, Plc Radiopharmaceuticals in Nuclear Medicine Sales, Revenue, Price and Gross Margin(2014-2019) 3.4.4 Main Business Overview 3.5 Eczacibasi-Monrol 3.5.1 Company Basic Information, Manufacturing Base and Competitors 3.5.2 Radiopharmaceuticals in Nuclear Medicine Product Category, Application and Specification 3.5.3 Eczacibasi-Monrol Radiopharmaceuticals in Nuclear Medicine Sales, Revenue, Price and Gross Margin(2014-2019) 3.5.4 Main Business Overview 3.6 Fujifilm Holdings Corporation 3.6.1 Company Basic Information, Manufacturing Base and Competitors 3.6.2 Radiopharmaceuticals in Nuclear Medicine Product Category, Application and Specification 3.6.3 Fujifilm Holdings Corporation Radiopharmaceuticals in Nuclear Medicine Sales, Revenue, Price and Gross Margin(2014-2019) 3.6.4 Main Business Overview 3.7 GE Healthcare (Subsidiary Of General Electric Company) 3.7.1 Company Basic Information, Manufacturing Base and Competitors 3.7.2 Radiopharmaceuticals in Nuclear Medicine Product Category, Application and Specification 3.7.3 GE Healthcare (Subsidiary Of General Electric Company) Radiopharmaceuticals in Nuclear Medicine Sales, Revenue, Price and Gross Margin(2014-2019) 3.7.4 Main Business Overview 3.8 IBA Group 3.8.1 Company Basic Information, Manufacturing Base and Competitors 3.8.2 Radiopharmaceuticals in Nuclear Medicine Product Category, Application and Specification 3.8.3 IBA Group Radiopharmaceuticals in Nuclear Medicine Sales, Revenue, Price and Gross Margin(2014-2019) 3.8.4 Main Business Overview 3.9 Isotec, Inc. (Sigma-Aldrich) 3.9.1 Company Basic Information, Manufacturing Base and Competitors 3.9.2 Radiopharmaceuticals in Nuclear Medicine Product Category, Application and Specification 3.9.3 Isotec, Inc. (Sigma-Aldrich) Radiopharmaceuticals in Nuclear Medicine Sales, Revenue, Price and Gross Margin(2014-2019) 3.9.4 Main Business Overview 3.10 Lantheus Medical Imaging, Inc. 3.10.1 Company Basic Information, Manufacturing Base and Competitors 3.10.2 Radiopharmaceuticals in Nuclear Medicine Product Category, Application and Specification 3.10.3 Lantheus Medical Imaging, Inc. Radiopharmaceuticals in Nuclear Medicine Sales, Revenue, Price and Gross Margin(2014-2019) 3.10.4 Main Business Overview 3.11 Nordion, Inc. 3.12 Ntp Radioisotopes (Pty), Ltd. 3.13 Siemens Healthcare (Subsidiary Of Siemens AG) 3.14 Taiyo Nippon Sanso Corporation 3.15 Urenco Limited 3.16 Rotem Industries, Ltd., Inc. 3.17 Australian Nuclear Association And Technology Organization (ANSTO) 3.18 Board of Radiation And Isotope Technology (BRIT) 3.19 Institute of Atomic Energy Polatom Radioisotope Centre 3.20 Institute of Isotopes Co., Ltd. 3.21 Institute Of Radioelement (IRE) 4 Radiopharmaceuticals in Nuclear Medicine Market Status and Outlook by Regions 4.1 Global Market Status and Outlook by Regions 4.1.1 Global Radiopharmaceuticals in Nuclear Medicine Market Size and CAGR by Regions 4.1.2 North America 4.1.3 Asia-Pacific 4.1.4 Europe 4.1.5 South America 4.1.6 Middle East and Africa 4.2 Global Radiopharmaceuticals in Nuclear Medicine Sales and Revenue by Regions 4.2.1 Global Radiopharmaceuticals in Nuclear Medicine Sales and Market Share by Regions (2014-2019) 4.2.2 Global Radiopharmaceuticals in Nuclear Medicine Revenue and Market Share by Regions (2014-2019) 4.2.3 Global Radiopharmaceuticals in Nuclear Medicine Sales, Revenue, Price and Gross Margin (2014-2019) 4.3 North America Radiopharmaceuticals in Nuclear Medicine Sales, Revenue, Price and Gross Margin 4.3.1 United States 4.3.2 Canada 4.3.3 Mexico 4.4 Europe Radiopharmaceuticals in Nuclear Medicine Sales, Revenue, Price and Gross Margin 4.4.1 Germany 4.4.2 UK 4.4.3 France 4.4.4 Italy 4.4.5 Russia 4.4.6 Turkey 4.5 Asia-Pacific Radiopharmaceuticals in Nuclear Medicine Sales, Revenue, Price and Gross Margin 4.5.1 China 4.5.2 Japan 4.5.3 Korea 4.5.4 Southeast Asia 4.5.4.1 Indonesia 4.5.4.2 Thailand 4.5.4.3 Malaysia 4.5.4.4 Philippines 4.5.4.5 Vietnam 4.5.5 India 4.5.6 Australia 4.6 South America Radiopharmaceuticals in Nuclear Medicine Sales, Revenue, Price and Gross Margin 4.6.1 Brazil 4.7 Middle East and Africa Radiopharmaceuticals in Nuclear Medicine Sales, Revenue, Price and Gross Margin 4.7.1 Egypt 4.7.2 GCC Countries 5 Radiopharmaceuticals in Nuclear Medicine Application/End Users 5.1 Radiopharmaceuticals in Nuclear Medicine Segment by Application 5.1.1 Diagnostic Application 5.1.2 Therapeutic Application 5.1.3 Research 5.1.4 Pharmaceutical 5.1.5 Other 5.2 Global Radiopharmaceuticals in Nuclear Medicine Product Segment by Application 5.2.1 Global Radiopharmaceuticals in Nuclear Medicine Sales by Application 5.2.2 Global Radiopharmaceuticals in Nuclear Medicine Sales and Market Share by Application (2014-2019) 6 Global Radiopharmaceuticals in Nuclear Medicine Market Forecast 6.1 Global Radiopharmaceuticals in Nuclear Medicine Sales, Revenue Forecast (2019-2025) 6.1.1 Global Radiopharmaceuticals in Nuclear Medicine Sales and Growth Rate Forecast (2019-2025) 6.1.1 Global Radiopharmaceuticals in Nuclear Medicine Revenue and Growth Rate Forecast (2019-2025) 6.2 Global Radiopharmaceuticals in Nuclear Medicine Forecast by Regions 6.2.1 North America Radiopharmaceuticals in Nuclear Medicine Sales and Revenue Forecast (2019-2025) 6.2.2 Europe Radiopharmaceuticals in Nuclear Medicine Sales and Revenue Forecast (2019-2025) 6.2.3 Asia-Pacific Radiopharmaceuticals in Nuclear Medicine Sales and Revenue Forecast (2019-2025) 6.2.3.1 China 6.2.3.2 Japan 6.2.3.3 Korea 6.2.3.4 Southeast Asia 6.2.3.5 India 6.2.3.6 Australia 6.2.4 South America Radiopharmaceuticals in Nuclear Medicine Sales and Revenue Forecast (2019-2025) 6.2.5 Middle East and Africa Radiopharmaceuticals in Nuclear Medicine Sales and Revenue Forecast (2019-2025) 6.2.5.1 Egypt 6.2.5.2 GCC Countries 6.3 Radiopharmaceuticals in Nuclear Medicine Forecast by Type 6.3.1 Global Radiopharmaceuticals in Nuclear Medicine Sales and Revenue Forecast by Type (2019-2025) 6.3.2 Diagnostic Radiopharmaceuticals Gowth Forecast 6.3.3 Therapy Radiopharmaceuticals Gowth Forecast 6.4 Radiopharmaceuticals in Nuclear Medicine Forecast by Application 6.4.1 Global Radiopharmaceuticals in Nuclear Medicine Sales Forecast by Application (2019-2025) 6.4.2 Global Radiopharmaceuticals in Nuclear Medicine Forecast in Diagnostic Application 6.4.3 Global Radiopharmaceuticals in Nuclear Medicine Forecast in Therapeutic Application 7 Radiopharmaceuticals in Nuclear Medicine Upstream Raw Materials 7.1 Radiopharmaceuticals in Nuclear Medicine Key Raw Materials 7.1.1 Key Raw Materials 7.1.2 Key Raw Materials Price 7.1.3 Raw Materials Key Suppliers 7.2 Manufacturing Cost Structure 7.2.1 Raw Materials 7.2.2 Labor Cost 7.2.3 Manufacturing Expenses 7.3 Radiopharmaceuticals in Nuclear Medicine Industrial Chain Analysis 8 Marketing Strategy Analysis, Distributors 8.1 Marketing Channel 8.1.1 Direct Marketing 8.1.2 Indirect Marketing 8.1.3 Marketing Channel Development Trend 8.2 Distributors 8.3 Downstream Customers 9 Research Findings and Conclusion Appendix Methodology/Research Approach Research Programs/Design Market Size Estimation Market Breakdown and Data Triangulation Data Source Secondary Sources Primary Sources Disclaimer

List of Tables and Figures Figure Radiopharmaceuticals in Nuclear Medicine Product Picture Figure Global Radiopharmaceuticals in Nuclear Medicine Revenue (Million USD) Status and Outlook (2014-2025) Figure Global Radiopharmaceuticals in Nuclear Medicine Sales (K Units) Status and Outlook (2014-2025) Figure Product Picture of Diagnostic Radiopharmaceuticals Table Major Players of Diagnostic Radiopharmaceuticals Figure Global Diagnostic Radiopharmaceuticals Sales (K Units) and Growth Rate (%)(2014-2018) Figure Product Picture of Therapy Radiopharmaceuticals Table Major Players of Therapy Radiopharmaceuticals Figure Global Therapy Radiopharmaceuticals Sales (K Units) and Growth Rate (%)(2014-2019) Figure Product Picture of Enriched Stable Isotopes Table Major Players of Enriched Stable Isotopes Figure Global Enriched Stable Isotopes Sales (K Units) and Growth Rate (%)(2014-2019) Table Global Radiopharmaceuticals in Nuclear Medicine Sales (K Units) and Growth Rate (%) Comparison by Type Table Global Radiopharmaceuticals in Nuclear Medicine Sales (K Units) by Type (2014-2019) Table Global Radiopharmaceuticals in Nuclear Medicine Sales Share (%) by Type (2014-2019) Figure Global Radiopharmaceuticals in Nuclear Medicine Sales Market Share (%) by Type (2014-2019) Figure Global Radiopharmaceuticals in Nuclear Medicine Sales Market Share (%) by Type in 2018 Table Global Radiopharmaceuticals in Nuclear Medicine Revenue (Million USD) by Type (2014-2019) Table Global Radiopharmaceuticals in Nuclear Medicine Revenue Share (%) by Type (2014-2019) Figure Global Radiopharmaceuticals in Nuclear Medicine Revenue Share (%) by Type (2014-2019) Figure 2018 Global Radiopharmaceuticals in Nuclear Medicine Revenue Market Share (%) by Type Table Global Radiopharmaceuticals in Nuclear Medicine Price (USD/Unit) by Type (2014-2019) Table Global Radiopharmaceuticals in Nuclear Medicine Sales (K Units) by Company (2014-2019) Table Global Radiopharmaceuticals in Nuclear Medicine Sales Share (%) by Company (2014-2019) Figure Global Radiopharmaceuticals in Nuclear Medicine Sales Share (%) by Company in 2018 Table Global Radiopharmaceuticals in Nuclear Medicine Revenue (Million USD) by Company (2014-2019) Table Global Radiopharmaceuticals in Nuclear Medicine Revenue Share (%) by Company (2014-2019) Figure Global Radiopharmaceuticals in Nuclear Medicine Revenue Share (%) by Company in 2018 Table Global Market Radiopharmaceuticals in Nuclear Medicine Average Price (USD/Unit) by Company (2014-2019) Table Global Radiopharmaceuticals in Nuclear Medicine Top Players Manufacturing Base Distribution and Sales Area Table Global Radiopharmaceuticals in Nuclear Medicine Top Players Product Category Figure Global Radiopharmaceuticals in Nuclear Medicine Market Share (%) of Top 5 Players Figure Global Radiopharmaceuticals in Nuclear Medicine Market Share (%) of Top 10 Players Table Bracco Imaging S.P.A. Basic Information List Table Bracco Imaging S.P.A. Radiopharmaceuticals in Nuclear Medicine Product Category, Application and Specification Table Bracco Imaging S.P.A. Radiopharmaceuticals in Nuclear Medicine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2014-2019) Figure Bracco Imaging S.P.A. Radiopharmaceuticals in Nuclear Medicine Sales Growth Rate (2014-2019) Figure Bracco Imaging S.P.A. Radiopharmaceuticals in Nuclear Medicine Sales Global Market Share (%)(2014-2019) Table Cambridge Isotope Laboratories, Inc. Basic Information List Figure Cambridge Isotope Laboratories, Inc. Radiopharmaceuticals in Nuclear Medicine Product Category, Application and Specification Table Cambridge Isotope Laboratories, Inc. Radiopharmaceuticals in Nuclear Medicine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2014-2019) Figure Cambridge Isotope Laboratories, Inc. Radiopharmaceuticals in Nuclear Medicine Sales Growth Rate (2014-2019) Figure Cambridge Isotope Laboratories, Inc. Radiopharmaceuticals in Nuclear Medicine Sales Global Market Share (%)(2014-2019) Table Cardinal Health, Inc. Basic Information List Figure Cardinal Health, Inc. Radiopharmaceuticals in Nuclear Medicine Product Category, Application and Specification Table Cardinal Health, Inc. Radiopharmaceuticals in Nuclear Medicine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2014-2019) Figure Cardinal Health, Inc. Radiopharmaceuticals in Nuclear Medicine Sales Growth Rate (2014-2019) Figure Cardinal Health, Inc. Radiopharmaceuticals in Nuclear Medicine Sales Global Market Share (%)(2014-2019) Table Covidien, Plc Basic Information List Figure Covidien, Plc Radiopharmaceuticals in Nuclear Medicine Product Category, Application and Specification Table Covidien, Plc Radiopharmaceuticals in Nuclear Medicine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2014-2019) Figure Covidien, Plc Radiopharmaceuticals in Nuclear Medicine Sales Growth Rate (2014-2019) Figure Covidien, Plc Radiopharmaceuticals in Nuclear Medicine Sales Global Market Share (%)(2014-2019) Table Eczacibasi-Monrol Basic Information List Figure Eczacibasi-Monrol Radiopharmaceuticals in Nuclear Medicine Product Category, Application and Specification Table Eczacibasi-Monrol Radiopharmaceuticals in Nuclear Medicine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2014-2019) Figure Eczacibasi-Monrol Radiopharmaceuticals in Nuclear Medicine Sales Growth Rate (2014-2019) Figure Eczacibasi-Monrol Radiopharmaceuticals in Nuclear Medicine Sales Global Market Share (%)(2014-2019) Table Fujifilm Holdings Corporation Basic Information List Figure Fujifilm Holdings Corporation Radiopharmaceuticals in Nuclear Medicine Product Category, Application and Specification Table Fujifilm Holdings Corporation Radiopharmaceuticals in Nuclear Medicine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2014-2019) Figure Fujifilm Holdings Corporation Radiopharmaceuticals in Nuclear Medicine Sales Growth Rate (2014-2019) Figure Fujifilm Holdings Corporation Radiopharmaceuticals in Nuclear Medicine Sales Global Market Share (%)(2014-2019) Table GE Healthcare (Subsidiary Of General Electric Company) Basic Information List Figure GE Healthcare (Subsidiary Of General Electric Company) Radiopharmaceuticals in Nuclear Medicine Product Category, Application and Specification Table GE Healthcare (Subsidiary Of General Electric Company) Radiopharmaceuticals in Nuclear Medicine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2014-2019) Figure GE Healthcare (Subsidiary Of General Electric Company) Radiopharmaceuticals in Nuclear Medicine Sales Growth Rate (2014-2019) Figure GE Healthcare (Subsidiary Of General Electric Company) Radiopharmaceuticals in Nuclear Medicine Sales Global Market Share (%)(2014-2019) Table IBA Group Basic Information List Figure IBA Group Radiopharmaceuticals in Nuclear Medicine Product Category, Application and Specification Table IBA Group Radiopharmaceuticals in Nuclear Medicine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2014-2019) Figure IBA Group Radiopharmaceuticals in Nuclear Medicine Sales Growth Rate (2014-2019) Figure IBA Group Radiopharmaceuticals in Nuclear Medicine Sales Global Market Share (%)(2014-2019) Table Isotec, Inc. (Sigma-Aldrich) Basic Information List Figure Isotec, Inc. (Sigma-Aldrich) Radiopharmaceuticals in Nuclear Medicine Product Category, Application and Specification Table Isotec, Inc. (Sigma-Aldrich) Radiopharmaceuticals in Nuclear Medicine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2014-2019) Figure Isotec, Inc. (Sigma-Aldrich) Radiopharmaceuticals in Nuclear Medicine Sales Growth Rate (2014-2019) Figure Isotec, Inc. (Sigma-Aldrich) Radiopharmaceuticals in Nuclear Medicine Sales Global Market Share (%)(2014-2019) Table Lantheus Medical Imaging, Inc. Basic Information List Figure Lantheus Medical Imaging, Inc. Radiopharmaceuticals in Nuclear Medicine Product Category, Application and Specification Table Lantheus Medical Imaging, Inc. Radiopharmaceuticals in Nuclear Medicine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2014-2019) Figure Lantheus Medical Imaging, Inc. Radiopharmaceuticals in Nuclear Medicine Sales Growth Rate (2014-2019) Figure Lantheus Medical Imaging, Inc. Radiopharmaceuticals in Nuclear Medicine Sales Global Market Share (%)(2014-2019) Table Nordion, Inc. Basic Information List Table Ntp Radioisotopes (Pty), Ltd. Basic Information List Table Siemens Healthcare (Subsidiary Of Siemens AG) Basic Information List Table Taiyo Nippon Sanso Corporation Basic Information List Table Urenco Limited Basic Information List Table Rotem Industries, Ltd., Inc. Basic Information List Table Australian Nuclear Association And Technology Organization (ANSTO) Basic Information List Table Board of Radiation And Isotope Technology (BRIT) Basic Information List Table Institute of Atomic Energy Polatom Radioisotope Centre Basic Information List Table Institute of Isotopes Co., Ltd. Basic Information List Table Institute Of Radioelement (IRE) Basic Information List Table Global Radiopharmaceuticals in Nuclear Medicine Market Size Comparison by Regions (2014-2025) Figure North America Radiopharmaceuticals in Nuclear Medicine Revenue (Million USD) and Growth Rate (%)(2014-2025) Figure Asia-Pacific Radiopharmaceuticals in Nuclear Medicine Revenue (Million USD) and Growth Rate (%)(2014-2025) Figure Europe Radiopharmaceuticals in Nuclear Medicine Revenue (Million USD) and Growth Rate (%)(2014-2025) Figure South America Radiopharmaceuticals in Nuclear Medicine Revenue (Million USD) and Growth Rate (%)(2014-2025) Figure Middle East and Africa Radiopharmaceuticals in Nuclear Medicine Revenue (Million USD) and Growth Rate (%)(2014-2025) Table Global Radiopharmaceuticals in Nuclear Medicine Sales (K Units) by Regions (2014-2019) Table Global Radiopharmaceuticals in Nuclear Medicine Sales Market Share (%) by Regions (2014-2019) Figure Global Radiopharmaceuticals in Nuclear Medicine Sales Market Share (%) by Regions (2014-2019) Figure 2018 Global Radiopharmaceuticals in Nuclear Medicine Sales Market Share (%) by Regions Table Global Radiopharmaceuticals in Nuclear Medicine Revenue (Million USD) by Regions (2014-2019) Table Global Radiopharmaceuticals in Nuclear Medicine Revenue Market Share (%) by Regions (2014-2019) Figure Global Radiopharmaceuticals in Nuclear Medicine Revenue Market Share (%) by Regions (2014-2019) Figure 2018 Global Radiopharmaceuticals in Nuclear Medicine Revenue Market Share (%) by Regions Table Global Radiopharmaceuticals in Nuclear Medicine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2014-2019) Figure North America Radiopharmaceuticals in Nuclear Medicine Sales Growth Rate Table North America Radiopharmaceuticals in Nuclear Medicine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2014-2019) Figure United States Radiopharmaceuticals in Nuclear Medicine Sales (K Units)(2014-2019) Figure United States Radiopharmaceuticals in Nuclear Medicine Revenue (Million USD)(2014-2019) Figure Canada Radiopharmaceuticals in Nuclear Medicine Sales (K Units)(2014-2019) Figure Canada Radiopharmaceuticals in Nuclear Medicine Revenue (Million USD)(2014-2019) Figure Mexico Radiopharmaceuticals in Nuclear Medicine Sales (K Units)(2014-2019) Figure Mexico Radiopharmaceuticals in Nuclear Medicine Revenue (Million USD)(2014-2019) Figure Europe Radiopharmaceuticals in Nuclear Medicine Sales Growth Rate Table Europe Radiopharmaceuticals in Nuclear Medicine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2014-2019) Figure Germany Radiopharmaceuticals in Nuclear Medicine Sales (K Units)(2014-2019) Figure Germany Radiopharmaceuticals in Nuclear Medicine Revenue (Million USD) (2014-2019) Figure UK Radiopharmaceuticals in Nuclear Medicine Sales (K Units)(2014-2019) Figure UK Radiopharmaceuticals in Nuclear Medicine Revenue (Million USD)(2014-2019) Figure France Radiopharmaceuticals in Nuclear Medicine Sales (K Units)(2014-2019) Figure France Radiopharmaceuticals in Nuclear Medicine Revenue (Million USD)(2014-2019) Figure Italy Radiopharmaceuticals in Nuclear Medicine Sales (K Units)(2014-2019) Figure Italy Radiopharmaceuticals in Nuclear Medicine Revenue (Million USD)(2014-2019) Figure Russia Radiopharmaceuticals in Nuclear Medicine Sales (K Units)(2014-2019) Figure Russia Radiopharmaceuticals in Nuclear Medicine Revenue (Million USD)(2014-2019) Figure Turkey Radiopharmaceuticals in Nuclear Medicine Sales (K Units)(2014-2019) Figure Turkey Radiopharmaceuticals in Nuclear Medicine Revenue (Million USD)(2014-2019) Figure Asia-Pacific Radiopharmaceuticals in Nuclear Medicine Sales Growth Rate Table Asia-Pacific Radiopharmaceuticals in Nuclear Medicine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2014-2019) Figure China Radiopharmaceuticals in Nuclear Medicine Sales (K Units)(2014-2019) Figure China Radiopharmaceuticals in Nuclear Medicine Revenue (Million USD)(2014-2019) Figure Japan Radiopharmaceuticals in Nuclear Medicine Sales (K Units)(2014-2019) Figure Japan Radiopharmaceuticals in Nuclear Medicine Revenue (Million USD)(2014-2019) Figure Korea Radiopharmaceuticals in Nuclear Medicine Sales (K Units)(2014-2019) Figure Korea Radiopharmaceuticals in Nuclear Medicine Revenue (Million USD)(2014-2019) Figure Southeast Asia Radiopharmaceuticals in Nuclear Medicine Sales (K Units)(2014-2019) Figure Southeast Asia Radiopharmaceuticals in Nuclear Medicine Revenue (Million USD)(2014-2019) Figure Indonesia Radiopharmaceuticals in Nuclear Medicine Sales (K Units)(2014-2019) Figure Indonesia Radiopharmaceuticals in Nuclear Medicine Revenue (Million USD)(2014-2019) Figure Thailand Radiopharmaceuticals in Nuclear Medicine Sales (K Units)(2014-2019) Figure Thailand Radiopharmaceuticals in Nuclear Medicine Revenue (Million USD)(2014-2019) Figure Malaysia Radiopharmaceuticals in Nuclear Medicine Sales (K Units)(2014-2019) Figure Malaysia Radiopharmaceuticals in Nuclear Medicine Revenue (Million USD)(2014-2019) Figure Philippines Radiopharmaceuticals in Nuclear Medicine Sales (K Units)(2014-2019) Figure Philippines Radiopharmaceuticals in Nuclear Medicine Revenue (Million USD)(2014-2019) Figure Vietnam Radiopharmaceuticals in Nuclear Medicine Sales (K Units)(2014-2019) Figure Vietnam Radiopharmaceuticals in Nuclear Medicine Revenue (Million USD)(2014-2019) Figure India Radiopharmaceuticals in Nuclear Medicine Sales (K Units)(2014-2019) Figure India Radiopharmaceuticals in Nuclear Medicine Revenue (Million USD)(2014-2019) Figure Australia Radiopharmaceuticals in Nuclear Medicine Sales (K Units)(2014-2019) Figure Australia Radiopharmaceuticals in Nuclear Medicine Revenue (Million USD)(2014-2019) Figure South America Radiopharmaceuticals in Nuclear Medicine Sales Growth Rate Table South America Radiopharmaceuticals in Nuclear Medicine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2014-2019) Figure Brazil Radiopharmaceuticals in Nuclear Medicine Sales (K Units)(2014-2019) Figure Brazil Radiopharmaceuticals in Nuclear Medicine Revenue (Million USD)(2014-2019) Figure Middle East and Africa Radiopharmaceuticals in Nuclear Medicine Sales Growth Rate Table Middle East and Africa Radiopharmaceuticals in Nuclear Medicine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2014-2019) Figure North Africa Radiopharmaceuticals in Nuclear Medicine Sales (K Units)(2014-2019) Figure North Africa Radiopharmaceuticals in Nuclear Medicine Revenue (Million USD)(2014-2019) Figure GCC Countries Radiopharmaceuticals in Nuclear Medicine Sales (K Units)(2014-2019) Figure GCC Countries Radiopharmaceuticals in Nuclear Medicine Revenue (Million USD)(2014-2019) Figure Diagnostic Application Examples Figure Therapeutic Application Examples Figure Research Examples Figure Pharmaceutical Examples Figure Other Examples Table Global Radiopharmaceuticals in Nuclear Medicine Sales (K Units) Comparison by Application (2014-2025) Table Global Radiopharmaceuticals in Nuclear Medicine Sales (K Units) by Application (2014-2019) Table Global Radiopharmaceuticals in Nuclear Medicine Sales Share (%) by Application (2014-2019) Figure Global Radiopharmaceuticals in Nuclear Medicine Sales Market Share (%) by Application (2014-2019) Figure Global Radiopharmaceuticals in Nuclear Medicine Sales Market Share (%) by Application in 2018 Figure Global Radiopharmaceuticals in Nuclear Medicine Sales (K Units) and Growth Rate (%) Forecast (2019-2025) Figure Global Radiopharmaceuticals in Nuclear Medicine Revenue (Million USD) and Growth Rate (%) Forecast (2019-2025) Table Global Radiopharmaceuticals in Nuclear Medicine Sales (K Units) Forecast by Regions (2019-2025) Figure Global Radiopharmaceuticals in Nuclear Medicine Sales Market Share (%) Forecast by Regions (2019-2025) Figure North America Radiopharmaceuticals in Nuclear Medicine Sales (K Units) and Growth Rate (%) Forecast (2019-2025) Figure North America Radiopharmaceuticals in Nuclear Medicine Revenue and Growth Rate (%) Forecast (2019-2025) Figure Europe Radiopharmaceuticals in Nuclear Medicine Sales (K Units) and Growth Rate (%) Forecast (2019-2025) Figure Europe Radiopharmaceuticals in Nuclear Medicine Revenue and Growth Rate (%) Forecast (2019-2025) Figure Asia-Pacific Radiopharmaceuticals in Nuclear Medicine Sales (K Units) and Growth Rate (%) Forecast (2019-2025) Figure Asia-Pacific Radiopharmaceuticals in Nuclear Medicine Revenue and Growth Rate (%) Forecast (2019-2025) Figure China Radiopharmaceuticals in Nuclear Medicine Sales (K Units) and Growth Rate (%) Forecast (2019-2025) Figure China Radiopharmaceuticals in Nuclear Medicine Revenue and Growth Rate (%) Forecast (2019-2025) Figure Japan Radiopharmaceuticals in Nuclear Medicine Sales (K Units) and Growth Rate (%) Forecast (2019-2025) Figure Japan Radiopharmaceuticals in Nuclear Medicine Revenue and Growth Rate (%) Forecast (2019-2025) Figure Korea Radiopharmaceuticals in Nuclear Medicine Sales (K Units) and Growth Rate (%) Forecast (2019-2025) Figure Korea Radiopharmaceuticals in Nuclear Medicine Revenue and Growth Rate (%) Forecast (2019-2025) Figure Southeast Asia Radiopharmaceuticals in Nuclear Medicine Sales (K Units) and Growth Rate (%) Forecast (2019-2025) Figure Southeast Asia Radiopharmaceuticals in Nuclear Medicine Revenue and Growth Rate (%) Forecast (2019-2025) Figure India Radiopharmaceuticals in Nuclear Medicine Sales (K Units) and Growth Rate (%) Forecast (2019-2025) Figure India Radiopharmaceuticals in Nuclear Medicine Revenue and Growth Rate (%) Forecast (2019-2025) Figure Australia Radiopharmaceuticals in Nuclear Medicine Sales (K Units) and Growth Rate (%) Forecast (2019-2025) Figure Australia Radiopharmaceuticals in Nuclear Medicine Revenue and Growth Rate (%) Forecast (2019-2025) Figure South America Radiopharmaceuticals in Nuclear Medicine Sales (K Units) and Growth Rate (%) Forecast (2019-2025) Figure South America Radiopharmaceuticals in Nuclear Medicine Revenue and Growth Rate (%) Forecast (2019-2025) Figure Middle East and Africa Radiopharmaceuticals in Nuclear Medicine Sales (K Units) and Growth Rate (%) Forecast (2019-2025) Figure Middle East and Africa Radiopharmaceuticals in Nuclear Medicine Revenue and Growth Rate (%) Forecast (2019-2025) Figure North Africa Radiopharmaceuticals in Nuclear Medicine Sales (K Units) and Growth Rate (%) Forecast (2019-2025) Figure North Africa Radiopharmaceuticals in Nuclear Medicine Revenue and Growth Rate (%) Forecast (2019-2025) Figure GCC Countries Radiopharmaceuticals in Nuclear Medicine Sales (K Units) and Growth Rate (%) Forecast (2019-2025) Figure GCC Countries Radiopharmaceuticals in Nuclear Medicine Revenue and Growth Rate (%) Forecast (2019-2025) Table Global Radiopharmaceuticals in Nuclear Medicine Sales (Million USD) Forecast by Type (2019-2025) Figure Global Radiopharmaceuticals in Nuclear Medicine Sales Market Share (%) Forecast by Type (2019-2025) Table Global Radiopharmaceuticals in Nuclear Medicine Revenue (Million USD) Forecast by Type (2019-2025) Figure Global Radiopharmaceuticals in Nuclear Medicine Revenue Market Share (%) Forecast by Type (2019-2025) Figure Diagnostic Radiopharmaceuticals Sales Growth Forecast Figure Therapy Radiopharmaceuticals Sales Growth Forecast Table Global Radiopharmaceuticals in Nuclear Medicine Sales (K Units) Forecast by Application (2019-2025) Figure Global Radiopharmaceuticals in Nuclear Medicine Sales Forecast by Application (2019-2025) Figure Global Radiopharmaceuticals in Nuclear Medicine Sales (K Units) Forecast in Diagnostic Application Figure Global Radiopharmaceuticals in Nuclear Medicine Sales (K Units) Forecast in Therapeutic Application Table Key Raw Materials Lists Figure Key Raw Materials Price Table Raw Materials Key Suppliers Lists Figure Radiopharmaceuticals in Nuclear Medicine Manufacturing Cost Structure Figure Radiopharmaceuticals in Nuclear Medicine Industrial Chain Analysis Table Distributors List Table Radiopharmaceuticals in Nuclear Medicine Downstream Customers

Bracco Imaging S.P.A. Cambridge Isotope Laboratories, Inc. Cardinal Health, Inc. Covidien, Plc Eczacibasi-Monrol Fujifilm Holdings Corporation GE Healthcare (Subsidiary Of General Electric Company) IBA Group Isotec, Inc. (Sigma-Aldrich) Lantheus Medical Imaging, Inc. Nordion, Inc. Ntp Radioisotopes (Pty), Ltd. Siemens Healthcare (Subsidiary Of Siemens AG) Taiyo Nippon Sanso Corporation Urenco Limited Rotem Industries, Ltd., Inc. Australian Nuclear Association And Technology Organization (ANSTO) Board of Radiation And Isotope Technology (BRIT) Institute of Atomic Energy Polatom Radioisotope Centre Institute of Isotopes Co., Ltd. Institute Of Radioelement (IRE)